US Home Infusion Therapy Devices Market Research Report: By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End User (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Forecast to 2035

US Home Infusion Therapy Devices Market Research Report: By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End User (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Forecast to 2035.

US Home Infusion Therapy Devices Market Overview:

As per MRFR analysis, the US Home Infusion Therapy Devices Market Size was estimated at 4.62 (USD Billion) in 2023. The US Home Infusion Therapy Devices Market Industry is expected to grow from 5(USD Billion) in 2024 to 10.5 (USD Billion) by 2035. The US Home Infusion Therapy Devices Market CAGR (growth rate) is expected to be around 6.978% during the forecast period (2025 - 2035).

Key US Home Infusion Therapy Devices Market Trends Highlighted

The US Home Infusion Therapy Devices Market is witnessing significant growth, driven by an increasing preference for home healthcare solutions. Factors such as the rising aging population, chronic diseases, and a shift towards outpatient care are fueling this trend. Additionally, advancements in technology are enhancing the safety and efficacy of infusion therapy, making it more appealing for both healthcare providers and patients. Healthcare reforms that emphasize cost-effective treatments further drive the adoption of home infusion therapies, as they reduce hospital stays and associated costs. Opportunities within this market are abound, particularly in developing advanced infusion devices and integrated delivery systems.The emphasis on personalized medicine is opening avenues for companies to create tailored infusion solutions, catering to specific patient needs. Moreover, home healthcare providers can expand their offerings through partnerships with technology firms to incorporate telehealth solutions, thus increasing patient engagement and monitoring efficiency. In recent times, the US market has also seen a rise in demand for infusion devices that are user-friendly, portable, and equipped with smart technology for remote monitoring. The ongoing developments related to telemedicine and home healthcare services have reshaped how patients receive treatment, further stimulating interest in home infusion therapy.Regulatory policies supporting patient care at home and the push to reduce hospital readmissions are reinforcing this trend. As more patients opt for home-based therapies due to comfort and convenience, the market will likely continue expanding to meet these evolving needs.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Home Infusion Therapy Devices Market Drivers

Increasing Prevalence of Chronic Diseases

The US Home Infusion Therapy Devices Market Industry is significantly driven by the increasing prevalence of chronic diseases, such as diabetes, heart disease, and cancer. According to the Centers for Disease Control and Prevention (CDC), approximately 6.2 million adults in the US are diagnosed with diabetes, which requires ongoing treatment that can be effectively administered through home infusion therapy devices. The rising demand for effective treatment options is further emphasized by the American Cancer Society, which reports that cancer rates are expected to rise by 24% by 2035, highlighting the urgent need for home-based healthcare solutions.As a result, healthcare providers and pharmaceutical companies are investing in Research and Development to enhance home infusion products, making them safer and more user-friendly, thereby expanding market growth in the US Home Infusion Therapy Devices Market.

Technological Advancements in Infusion Systems

Technological advancements in infusion systems play a pivotal role in the growth of the US Home Infusion Therapy Devices Market Industry. The integration of smart technology, including mobile health applications and remote monitoring, is transforming how infusion therapy is administered at home. According to the US Food and Drug Administration (FDA), there has been a steady increase in the number of infusion devices receiving regulatory approval, which serves as a testament to the rapid innovation in this field.Leading companies such as Baxter International and Smiths Medical are at the forefront of developing advanced infusion delivery systems that enhance patient safety and ease of use, ultimately driving market expansion.

Rising Focus on Cost-Effective Healthcare Solutions

The trend towards cost-effective healthcare solutions is a significant driver for the US Home Infusion Therapy Devices Market Industry. The increasing pressure on healthcare systems to reduce expenditures has led to a growing preference for home-based treatment options. The Medicare Payment Advisory Commission reported that home infusion therapy can reduce hospital readmission rates and associated costs by approximately 30%, providing a compelling argument for healthcare providers and payers.As a result, various stakeholders in the healthcare sector are increasingly promoting home infusion therapy as a viable alternative to traditional inpatient treatments, sparking growth in this market segment.

Expansion of Home Healthcare Services

The expansion of home healthcare services is a crucial factor fueling the US Home Infusion Therapy Devices Market Industry. As the demand for at-home care increases, fueled by an aging population and a preference for home-based care, healthcare providers are broadening their services to include home infusion therapy. According to the National Association for Home Care and Hospice, an estimated 12 million patients receive home healthcare each year in the US, with this number expected to rise due to demographic changes.This shift in care delivery models encourages the adoption of home infusion devices, creating significant opportunities for market participants to enhance their offerings and meet the growing needs of patients.

US Home Infusion Therapy Devices Market Segment Insights:

Home Infusion Therapy Devices Market Device Type Insights

The Device Type segment within the US Home Infusion Therapy Devices Market plays a pivotal role in shaping the overall landscape of the industry, which is experiencing substantial growth driven by technological advancements and increasing patient demand for at-home care solutions. Infusion Pumps are essential devices used for delivering medications and nutrients efficiently, providing precision and control that are crucial for patient treatment outcomes. Syringe Pumps offer versatility, often preferred for administering smaller volumes of fluids, and are widely utilized in cases where accuracy is paramount.Ambulatory Pumps facilitate patient mobility by allowing individuals to receive therapy on the go, thereby enhancing comfort and independence while managing chronic conditions. Enteral Feeding Pumps are specialized devices aimed at patients requiring nutritional support, ensuring that timely and adequate food intake is maintained even outside of traditional clinical settings. The integration of these devices is essential for addressing the growing patient population seeking home healthcare services, driven by the rising prevalence of chronic diseases and a significant shift towards personalized medicine.Furthermore, home-based infusion therapy not only curtails hospital stays, thereby reducing healthcare costs, but also empowers patients to partake in their treatment journey from the comfort of their homes. Market dynamics reveal a notable trend toward the incorporation of smart technology in these devices, allowing for enhanced monitoring and user-friendly interfaces that improve patient safety and adherence to therapy protocols. Given these factors, the Device Type segment is projected to continue to evolve, paving the way for innovative solutions that cater to diverse treatment needs and setting a foundation for robust future growth within the US Home Infusion Therapy Devices Market.As patient preferences shift towards home treatment options, the significance of these devices in healthcare delivery is anticipated to expand, supported by a favorable regulatory framework and an increasing focus on value-based care initiatives. The collective momentum of these factors positions the Device Type segment as a key driver in transforming home infusion therapy into a more practical and effective option for a wide range of patients.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Home Infusion Therapy Devices Market Therapy Type Insights

The US Home Infusion Therapy Devices Market has shown significant growth attributed to the increasing demand across various Therapy Types such as Antibiotic Therapy, Chemotherapy, Nutrition Therapy, and Pain Management. Antibiotic Therapy is particularly critical for managing infections and is gaining traction due to the rising prevalence of chronic infections and the aging population in the US. Chemotherapy remains essential for cancer management, with patients preferring home-based therapies for convenience and comfort. Nutrition Therapy, especially for patients with malnutrition or specific dietary needs, is experiencing increased adoption, thereby improving patient quality of life.Additionally, Pain Management therapy is vital for patients suffering from chronic pain conditions, offering a significant alternative to traditional pain relief methods. This diversity in therapy types underscores the US Home Infusion Therapy Devices Market segmentation, revealing distinct needs and growth potentials. The growing trend towards home-based healthcare solutions, catalyzed by advancements in technology, challenges for healthcare access, and evolving patient preferences, supports the expansion of all these therapy types in the market.Each segment presents unique opportunities, particularly in enhancing patient compliance and management through tailored home infusion solutions.

Home Infusion Therapy Devices Market End User Insights

The End User segment of the US Home Infusion Therapy Devices Market plays a vital role in shaping the overall dynamics of this industry. Hospitals serve as a critical hub for the administration of these devices, supporting complex cases that require specialized care. With an increasing focus on patient-centered care, Home Care Settings are gaining significant traction, allowing patients to receive treatment in the comfort of their homes, thereby improving recovery experiences and overall satisfaction. Nursing Homes, on the other hand, are essential for managing chronic conditions among elderly populations, forming a crucial part of the healthcare continuum in the US.This growing trend can be attributed to the US government's emphasis on reducing hospital stays, resulting in an increased demand for effective home-based therapies. The segmentation of the US Home Infusion Therapy Devices Market illustrates the diverse needs of various patient populations, highlighting the opportunities for tailored solutions that enhance patient outcomes and operational efficiency across these different settings. Moreover, the aging population and rising prevalence of chronic diseases are expected to drive growth within these specific user segments, making them increasingly important in addressing contemporary healthcare challenges.

Home Infusion Therapy Devices Market Components Insights

The Components segment of the US Home Infusion Therapy Devices Market plays a crucial role in enhancing the efficiency and safety of home-based treatment protocols. This segment includes essential elements such as Infusion Sets, Catheters, Accessories, and Software Solutions, each being vital for patient care and treatment management. Infusion Sets are instrumental in delivering medications directly into the bloodstream, ensuring precise dosing and minimizing complications. Catheters facilitate easy access to veins while reducing the risk of infections, thus making them indispensable for patients requiring long-term therapy.Meanwhile, Accessories are essential for maintaining the integrity and functionality of infusion systems. Software Solutions are increasingly important as they support healthcare professionals in monitoring treatment progress and managing patient data more efficiently. This market is witnessing steady growth, driven by factors such as the increasing prevalence of chronic diseases in the US and the growing preference for home healthcare services. With technological advancements and a rising aging population, the Components segment is poised to become increasingly significant in the overall landscape of home infusion therapy.

US Home Infusion Therapy Devices Market Key Players and Competitive Insights:

The US Home Infusion Therapy Devices Market has been experiencing considerable growth, driven by an increasing number of patients opting for home-based treatment solutions. This shift is attributed to various factors, including the rising preference for home healthcare services, technological advancements in infusion delivery systems, and the cost-effective nature of home therapies as compared to hospital stays. The landscape is marked by a mix of established players who have significant market share and new entrants looking to capitalize on the growing demand for personalized care solutions. As competition intensifies, companies are focusing on innovation, product differentiation, and strategic partnerships to enhance their market position, ensuring they meet evolving patient needs and regulatory requirements.Parker Hannifin has emerged as a strong player within the US Home Infusion Therapy Devices Market, recognized for its commitment to quality and innovation. The company's strengths lie in its advanced fluid control systems, which provide reliable and accurate infusion therapies for patients in home settings. Parker Hannifin has built a reputation for delivering cutting-edge technology and solutions designed to enhance patient outcomes and streamline healthcare provider workflows. Additionally, its robust distribution network and strong customer support contribute to its market presence, allowing for effective reach within the highly competitive home infusion segment. The company continues to invest in research and development, ensuring that its product offerings remain at the forefront of therapy advancements, thus reinforcing its competitive advantage in the market.C.R. Bard plays a significant role in the US Home Infusion Therapy Devices Market, focusing on providing a wide range of products designed specifically for infusion therapy. With a robust portfolio that includes catheters, infusion sets, and related accessories, C.R. Bard is well-positioned to meet the demands of healthcare professionals and patients alike. The company has established a strong market presence, characterized by its focus on quality, safety, and innovation. C.R. Bard is recognized for its strategic mergers and acquisitions, which have bolstered its capabilities and expanded its product offerings within the home infusion space. Its commitment to research and development fosters ongoing product innovation, pushing the boundaries of infusion technology. These strengths enable C.R. Bard to maintain a competitive edge and ensure it remains a trusted supplier within the home healthcare sector in the United States.

Key Companies in the US Home Infusion Therapy Devices Market Include:

Parker Hannifin

C.R. Bard

Hospira

Smiths Medical

CareFusion

Terumo Corporation

Medtronic

Baxter International

Fresenius Kabi

B. Braun Melsungen

Amgen

ICU Medical

Halyard Health

Becton Dickinson

Alpha Vantage

US Home Infusion Therapy Devices Market Industry Developments

The US Home Infusion Therapy Devices Market has recently been influenced by significant developments, including advancements in technology and an increasing shift towards home healthcare. Companies such as Baxter International and Medtronic are focusing on innovative infusion devices designed to enhance patient safety and comfort. In October 2023, C.R. Bard announced a strategic partnership aimed at expanding their product range in the home infusion sector. Growth in market valuation for firms like Fresenius Kabi and B. Braun Melsungen is also notable, with recent projections indicating a surge in demand for at-home healthcare solutions driven by the aging population and preference for at-home treatments. The COVID-19 pandemic catalyzed changes in healthcare delivery, intensifying interest in home infusion therapies. In terms of mergers and acquisitions, Smiths Medical completed the acquisition of CareFusion in September 2022 to strengthen its portfolio in the home infusion segment. Furthermore, in July 2022, ICU Medical acquired the assets of Halyard Health, further consolidating its position in the market. Overall, the landscape of the US Home Infusion Therapy Devices Market continues to evolve, supported by a focus on innovation and partnerships.

US Home Infusion Therapy Devices Market Segmentation Insights

Home Infusion Therapy Devices Market Device Type Outlook

Infusion Pumps

Syringe Pumps

Ambulatory Pumps

Enteral Feeding Pumps

Home Infusion Therapy Devices Market Therapy Type Outlook

Antibiotic Therapy

Chemotherapy

Nutrition Therapy

Pain Management

Home Infusion Therapy Devices Market End User Outlook

Hospitals

Home Care Settings

Nursing Homes

Home Infusion Therapy Devices Market Components Outlook

Infusion Set

Catheters

Accessories

Software Solutions

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	4.62(USD Billion)
MARKET SIZE 2024	5.0(USD Billion)
MARKET SIZE 2035	10.5(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.978% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Parker Hannifin, C.R. Bard, Hospira, Smiths Medical, CareFusion, Terumo Corporation, Medtronic, Baxter International, Fresenius Kabi, B. Braun Melsungen, Amgen, ICU Medical, Halyard Health, Becton Dickinson, Alpha Vantage
SEGMENTS COVERED	Device Type, Therapy Type, End User, Components
KEY MARKET OPPORTUNITIES	Aging population demand, Chronic disease management growth, Increasing preference for home care, Advancements in infusion technology, Cost-effective treatment solutions
KEY MARKET DYNAMICS	Aging population, Rising chronic diseases, Increasing home healthcare adoption, Technological advancements, Cost-effective treatment options
COUNTRIES COVERED	US